Logo for SenzaGen

SenzaGen Investor Relations Material

Latest events

Logo for SenzaGen

Q1 2024

SenzaGen
Logo for SenzaGen

Q1 2024

15 May, 2024
Logo for SenzaGen

Q4 2023

14 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from SenzaGen

Access all reports
SenzaGen AB develops, performs, and sells non-animal tests for assessing a substance's allergenicity. The company offers modified human cell lines that can be induced to react with a wide variety of chemicals and cell genes that may be activated by specific substances. SenzaGen AB was incorporated in 2000 and is based in Lund, Sweden. As of February 19, 2016, SenzaGen AB operates as a subsidiary of Ascendis Pharma A/S.